Literature DB >> 2431191

Role for angiotensin II in an overt functional proteinuria.

T Yoshioka, T Mitarai, V Kon, W M Deen, H G Rennke, I Ichikawa.   

Abstract

A partial renal vein constriction (RVC) was induced acutely in Munich-Wistar rats. RVC caused a marked reduction in glomerular plasma flow rate, and rises in glomerular transcapillary hydraulic pressure difference and efferent arteriolar resistance. These changes were associated with a marked increase in urinary protein excretion, on average from a baseline level of 8 to approximately 120 mg/24 hrs per kidney. Infusion of saralasin, an angiotensin II (AII) antagonist, largely normalized these indices, including urinary protein excretion (to approximately 35 mg/24 hrs per kidney), despite continued RVC. In separate rats, fractional clearances of neutral [125I]dextrans (molecular radii = 18-60 A) (CDEX/CIN) were measured. RVC caused a significant increase in CDEX/CIN for large dextrans (greater than or equal to 44A), but not small dextrans (less than or equal to 42A). Saralasin infusion led to a partial return toward baseline values of CDEX/CIN for the large dextrans. On the basis of the heteroporous membrane theory for glomerular filtration, the glomerular sieving defect during RVC was attributed to an increase in the relative fluid flux through a group of large non-selective pores. A marked alteration in glomerular microcirculatory pattern induced by enhanced action of endogenous AII in turn seemed to account largely, although not entirely, for the impairment of glomerular size-selectivity during RVC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431191     DOI: 10.1038/ki.1986.219

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Mechanism of orthostatic proteinuria.

Authors:  V M Vehaskari
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

3.  Left renal vein entrapment.

Authors:  P S Kurtin
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

4.  Nutcracker syndrome manifesting with severe proteinuria: a challenging scenario in a single-kidney patient.

Authors:  Z Birsin Ozçakar; Fatoş Yalçınkaya; Suat Fitöz; Gökhan Cipe; Tarkan Soygür; Handan Ozdemir; Cüneyt Köksoy
Journal:  Pediatr Nephrol       Date:  2011-02-13       Impact factor: 3.714

5.  Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.

Authors:  A Remuzzi; S Puntorieri; C Battaglia; T Bertani; G Remuzzi
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

6.  The utility of bioimpedance analysis for monitoring the children with nutcracker syndrome.

Authors:  Sevgi Yavuz; Aysel Kıyak; Ali Er; Orhan Korkmaz
Journal:  Eur J Pediatr       Date:  2015-04-29       Impact factor: 3.183

7.  Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.

Authors:  K Takahashi; G F Schreiner; K Yamashita; B W Christman; I Blair; K F Badr
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.

Authors:  T Yoshioka; H Shiraga; Y Yoshida; A Fogo; A D Glick; W M Deen; J R Hoyer; I Ichikawa
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 9.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 10.  Nondiabetic consequences of obesity on kidney.

Authors:  Tarak Srivastava
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.